Why the study?
The role of sleep disordered breathing treatment in patients with atrial fibrillation is highly dynamic, prompting a summary of recent insights to better understand proper management.
Does management of sleep disordered breathing reduce the incidence, burden, and recurrence of atrial fibrillation in patients with sleep disordered breathing?
Does management of sleep disordered breathing reduce the incidence, burden, and recurrence of atrial fibrillation in patients with sleep disordered breathing?
This commentary highlights the importance of identifying and managing sleep disordered breathing as a modifiable risk factor to reduce the burden and recurrence of atrial fibrillation.
The discussion around the role of sleep disordered breathing (SDB) treatment in patients with atrial fibrillation (AF) is highly dynamic [1].In the current guideline of the European Society of Cardiology for diagnosis and management of AF, the importance of identification and management of established AF-promoting risk factors, including SDB, and unhealthy lifestyle is addressed and clearly recommended [2].In patients with SDB, opportunistic screening for AF should be considered.Additionally, optimal management of SDB may be considered, to reduce incidence, burden, and recurrence of AF, along with improvement of symptoms.In this commentary, we summarize recent insights in this area which may help to better understand the value of proper SDB management in AF patients.
No takes yet. Share an insight, caveat, or question.
Linz et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: